Literature DB >> 12871571

Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A).

Tonya C Murphy1, Venkataraman Amarnath, K Michael Gibson, Matthew J Picklo.   

Abstract

Elevated levels of 4-hydroxy-trans-2-nonenal (HNE) are implicated in the pathogenesis of numerous neurodegenerative disorders. Although well-characterized in the periphery, the mechanisms of detoxification of HNE in the CNS are unclear. HNE is oxidized to a non-toxic metabolite in the rat cerebral cortex by mitochondrial aldehyde dehydrogenases (ALDHs). Two possible ALDH enzymes which might oxidize HNE in CNS mitochondria are ALDH2 and succinic semialdehyde dehydrogenase (SSADH/ALDH5A). It was previously established that hepatic ALDH2 can oxidize HNE. In this work, we tested the hypothesis that SSADH oxidizes HNE. SSADH is critical in the detoxification of the GABA metabolite, succinic semialdehyde (SSA). Recombinant rat SSADH oxidized HNE and other alpha,beta-unsaturated aldehydes. Inhibition and competition studies in rat brain mitochondria showed that SSADH was the predominant oxidizing enzyme for HNE but only contributed a portion of the total oxidizing activity in liver mitochondria. In vivo administration of diethyldithiocarbamate (DEDC) effectively inhibited (86%) ALDH2 activity but not HNE oxidation in liver mitochondria. The data suggest that a relationship between the detoxification of SSA and the neurotoxic aldehyde HNE exists in the CNS. Furthermore, these studies show that multiple hepatic aldehyde dehydrogenases are able to oxidize HNE.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12871571     DOI: 10.1046/j.1471-4159.2003.01839.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  20 in total

Review 1.  Succinic semialdehyde dehydrogenase: biochemical-molecular-clinical disease mechanisms, redox regulation, and functional significance.

Authors:  Kyung-Jin Kim; Phillip L Pearl; Kimmo Jensen; O Carter Snead; Patrizia Malaspina; Cornelis Jakobs; K Michael Gibson
Journal:  Antioxid Redox Signal       Date:  2011-04-10       Impact factor: 8.401

Review 2.  Thirty years beyond discovery--clinical trials in succinic semialdehyde dehydrogenase deficiency, a disorder of GABA metabolism.

Authors:  Kara R Vogel; Phillip L Pearl; William H Theodore; Robert C McCarter; Cornelis Jakobs; K Michael Gibson
Journal:  J Inherit Metab Dis       Date:  2012-06-28       Impact factor: 4.982

Review 3.  Protein carbonylation, mitochondrial dysfunction, and insulin resistance.

Authors:  Brigitte I Frohnert; David A Bernlohr
Journal:  Adv Nutr       Date:  2013-03-01       Impact factor: 8.701

4.  The genotypic and phenotypic spectrum of pyridoxine-dependent epilepsy due to mutations in ALDH7A1.

Authors:  Gunter Scharer; Chad Brocker; Vasilis Vasiliou; Geralyn Creadon-Swindell; Renata C Gallagher; Elaine Spector; Johan L K Van Hove
Journal:  J Inherit Metab Dis       Date:  2010-09-03       Impact factor: 4.982

5.  SSADH variation in primates: intra- and interspecific data on a gene with a potential role in human cognitive functions.

Authors:  Paola Blasi; Francesca Palmerio; Aurora Aiello; Mariano Rocchi; Patrizia Malaspina; Andrea Novelletto
Journal:  J Mol Evol       Date:  2006-06-17       Impact factor: 2.395

6.  Therapeutic relevance of mTOR inhibition in murine succinate semialdehyde dehydrogenase deficiency (SSADHD), a disorder of GABA metabolism.

Authors:  K R Vogel; G R Ainslie; E E W Jansen; G S Salomons; K M Gibson
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-17       Impact factor: 5.187

Review 7.  Cell death and diseases related to oxidative stress: 4-hydroxynonenal (HNE) in the balance.

Authors:  S Dalleau; M Baradat; F Guéraud; L Huc
Journal:  Cell Death Differ       Date:  2013-10-04       Impact factor: 15.828

8.  Effects of 1,4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo.

Authors:  Angela M Sgaravatti; Alessandra S Magnusson; Amanda S Oliveira; Caroline P Mescka; Fernanda Zanin; Mirian B Sgarbi; Carolina D Pederzolli; Angela T S Wyse; Clóvis M D Wannmacher; Moacir Wajner; Carlos S Dutra-Filho
Journal:  Metab Brain Dis       Date:  2009-03-19       Impact factor: 3.584

9.  Evidence for oxidative stress in tissues derived from succinate semialdehyde dehydrogenase-deficient mice.

Authors:  A Latini; K Scussiato; G Leipnitz; K M Gibson; M Wajner
Journal:  J Inherit Metab Dis       Date:  2007-09-21       Impact factor: 4.982

Review 10.  Comparative genomics of aldehyde dehydrogenase 5a1 (succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency.

Authors:  Patrizia Malaspina; Matthew J Picklo; C Jakobs; O Carter Snead; K Michael Gibson
Journal:  Hum Genomics       Date:  2009-01       Impact factor: 4.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.